[1] Longo, D., Fauci, A., Kasper, D., Hauser, S., Jameson, J. and Loscalzo, J. (2011) Harrison’s Principles of Internal Medicine. McGraw Hill Professional.
[2] Molodecky, N.A., Soon, I.S., Rabi, D.M., Ghali, W.A., Ferris, M., Chernoff, G., et al. (2012) Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases with Time, Based on Systematic Review. Gastroenterology, 142, 46-54.
[3] Scarpa, M. and Stylianou, E. (2012) Epigenetics: Concepts and Relevance to IBD Pathogenesis. Inflammatory Bowel Diseases, 18, 1982-1996.
http://dx.doi.org/10.1002/ibd.22934
[4] Glocker, E. and Grimbacher, B. (2012) Inflammatory Bowel Disease: Is It a Primary Immunodeficiency? Cellular and Molecular Life Sciences, 69, 41-48.
http://dx.doi.org/10.1007/s00018-011-0837-9
[5] Hendrickson, B.A., Gokhale, R. and Cho, J.H. (2002) Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease. Clinical Microbiology Reviews, 15, 79-94.
http://dx.doi.org/10.1128/CMR.15.1.79-94.2002
[6] Khor, B., Gardet, A. and Xavier, R.J. (2011) Genetics and Pathogenesis of Inflammatory Bowel Disease. Nature, 474, 307-317.
http://dx.doi.org/10.1038/nature10209
[7] Hollander, D., Vadheim, C.M., Brettholz, E., Petersen, G.M., Delahunty, T. and Rotter, J.I. (1986) Increased Intestinal Permeability in Patients with Crohn’s Disease and Their Relatives: A Possible Etiologic Factor. Annals of Internal Medicine, 105, 883-885.
http://dx.doi.org/10.7326/0003-4819-105-6-883
[8] Ukabam, S., Clamp, J. and Cooper, B. (1983) Abnormal Small Intestinal Permeability to Sugars in Patients with Crohn’s Disease of the Terminal Ileum and Colon. Digestion, 27, 70-74.
http://dx.doi.org/10.1159/000198932
[9] Hollander, D. (1988) Crohn’s Disease—A Permeability Disorder of the Tight Junction? Gut, 29, 1621-1624.
http://dx.doi.org/10.1136/gut.29.12.1621
[10] Halliwell, B. and Gutteridge, J. (1999) Oxygen Is a Toxic Gas: An Introduction to Oxygen Toxicity and Reactive Oxygen Species. Free Radicals in Biology and Medicine, 3, 1-35.
[11] Aruoma, O.I., Kaur, H. and Halliwell, B. (1991) Oxygen Free Radicals and Human Diseases. The Journal of the Royal Society for the Promotion of Health, 111, 172-177.
http://dx.doi.org/10.1177/146642409111100506
[12] Halliwell, B. and Gutteridge, J. (1985) Free Radicals in Biology and Medicine. Pergamon.
[13] Harris, M.L., Schiller, H.J., Reilly, P.M., Donowitz, M., Grisham, M.B. and Bulkley, G.B. (1992) Free Radicals and Other Reactive Oxygen Metabolites in Inflammatory Bowel Disease: Cause, Consequence or Epiphenomenon? Pharmacology & Therapeutics, 53, 375-408.
http://dx.doi.org/10.1016/0163-7258(92)90057-7
[14] Rezaie, A., Parker, R.D. and Abdollahi, M. (2007) Oxidative Stress and Pathogenesis of Inflammatory Bowel Disease: An Epiphenomenon or the Cause? Digestive Diseases and Sciences, 52, 2015-2021.
http://dx.doi.org/10.1007/s10620-006-9622-2
[15] Lih-Brody, L., Powell, S.R., Collier, K.P., Reddy, G.M., Cerchia, R., Kahn, E., et al. (1996) Increased Oxidative Stress and Decreased Antioxidant Defenses in Mucosa of Inflammatory Bowel Disease. Digestive Diseases and Sciences, 41, 2078-2086.
http://dx.doi.org/10.1007/BF02093613
[16] Hoffenberg, E.J., Deutsch, J., Smith, S. and Sokol, R.J. (1997) Circulating Antioxidant Concentrations in Children with Inflammatory Bowel Disease. The American Journal of Clinical Nutrition, 65, 1482-1488.
[17] Koutroubakis, I.E., Malliaraki, N., Dimoulios, P.D., Karmiris, K., Castanas, E. and Kouroumalis, E.A. (2004) Decreased Total and Corrected Antioxidant Capacity in Patients with Inflammatory Bowel Disease. Digestive Diseases and Sciences, 49, 1433-1437.
http://dx.doi.org/10.1023/B:DDAS.0000042242.22898.d9
[18] Ioannidis, O., Varnalidis, I., Paraskevas, G. and Botsios, D. (2011) Nutritional Modulation of the Inflammatory Bowel Response. Digestion, 84, 89-101.
http://dx.doi.org/10.1159/000323456
[19] D’Odorico, A., Bortolan, S., Cardin, R., D’Inca’, R., Martines, D., Ferronato, A. and Sturniolo, G.C. (2001) Reduced Plasma Antioxidant Concentrations and Increased Oxidative DNA Damage in Inflammatory Bowel Disease. Scandinavian Journal of Gastroenterology, 36, 1289-1294.
http://dx.doi.org/10.1080/003655201317097146
[20] Achitei, D., Ciobica, A., Balan, G., Gologan, E., Stanciu, C. and Stefanescu, G. (2013) Different Profile of Peripheral Antioxidant Enzymes and Lipid Peroxidation in Active and Non-Active Inflammatory Bowel Disease Patients. Digestive Diseases and Sciences, 58, 1244-1249.
http://dx.doi.org/10.1007/s10620-012-2510-z
[21] Hengstermann, S., Valentini, L., Schaper, L., Buning, C., Koernicke, T., Maritschnegg, M., et al. (2008) Altered Status of Antioxidant Vitamins and Fatty Acids in Patients with Inactive Inflammatory Bowel Disease. Clinical Nutrition, 27, 571-578.
http://dx.doi.org/10.1016/j.clnu.2008.01.007
[22] Alamdari, D.H., Paletas, K., Pegiou, T., Sarigianni, M., Befani, C. and Koliakos, G. (2007) A Novel Assay for the Evaluation of the Prooxidant-Antioxidant Balance, before and after Antioxidant Vitamin Administration in Type II Diabetes Patients. Clinical Biochemistry, 40, 248-254.
http://dx.doi.org/10.1016/j.clinbiochem.2006.10.017
[23] Kruidenier, L., Kuiper, I., van Duijn, W., Mieremet-Ooms, M.A., van Hogezand, R.A., Lamers, C.B., et al. (2003) Imbalanced Secondary Mucosal Antioxidant Response in Inflammatory Bowel Disease. The Journal of Pathology, 201, 17-27.
http://dx.doi.org/10.1002/path.1408